1. Home
  2. ENSC vs OMH Comparison

ENSC vs OMH Comparison

Compare ENSC & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.43

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.11

Market Cap

3.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENSC
OMH
Founded
2003
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.9M
3.2M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
ENSC
OMH
Price
$0.43
$0.11
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
21.4M
31.8M
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
65.24
N/A
EPS
N/A
N/A
Revenue
$5,066,650.00
N/A
Revenue This Year
$55.01
$28.40
Revenue Next Year
$1,033.97
$23.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.09
52 Week High
$2.75
$2.19

Technical Indicators

Market Signals
Indicator
ENSC
OMH
Relative Strength Index (RSI) 65.10 38.05
Support Level $0.27 N/A
Resistance Level $0.65 $1.09
Average True Range (ATR) 0.08 0.17
MACD 0.02 0.00
Stochastic Oscillator 27.08 1.76

Price Performance

Historical Comparison
ENSC
OMH

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.

Share on Social Networks: